Silk road medical, inc. (SILK)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
Cash flows from operating activities
Net loss

-38,198

-52,415

-59,743

-60,689

-56,380

-37,630

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense

722

712

722

736

634

517

0

0

0

Stock-based compensation expense

4,008

2,977

2,249

1,519

1,011

911

0

0

0

Change in fair value of redeemable convertible preferred stock warrant liability

5,318

21,030

28,029

31,258

27,834

11,906

0

0

0

Amortization of premium on investments

0

-

-

-

0

-

-

-

-

Amortization of debt discount and debt issuance costs

47

46

45

44

56

68

0

0

0

Amortization of right-of-use asset

566

582

0

0

0

-

-

-

-

Non-cash interest expense

284

672

997

1,328

1,640

1,555

0

0

0

Change in provision for doubtful accounts receivable

17

23

-215

-62

-404

-123

0

0

0

Provision for excess and obsolete inventories

183

118

101

66

50

23

0

0

0

Changes in assets and liabilities
Accounts receivable

2,458

2,241

2,506

2,543

2,301

446

0

0

0

Inventories

4,228

4,696

4,249

4,773

4,471

2,565

0

0

0

Prepaid expenses and other current assets

504

1,471

2,787

2,491

725

1,128

0

0

0

Other assets

-1,258

-552

-760

-746

730

62

0

0

0

Accounts payable

-398

615

968

-378

2,222

-309

0

0

0

Accrued liabilities

731

4,964

5,899

5,230

6,241

5,023

0

0

0

Other liabilities

97

-769

-608

-210

-663

406

0

0

0

Net cash used in operating activities

-32,785

-29,610

-29,739

-29,760

-25,665

-21,695

0

0

0

Cash flows from investing activities
Purchases of property and equipment

552

535

445

1,478

1,938

2,276

0

0

0

Purchases of investments

0

-

-

-

0

-

-

-

-

Proceeds from maturity of investments

0

-

-

-

0

-

-

-

-

Net cash used in investing activities

-69,947

-69,956

-439

-1,472

-1,932

-2,270

0

0

0

Cash flows from financing activities
Payment of deferred offering costs

0

-

-

-

0

-

-

-

0

Proceeds from issuance of common stock

2,489

2,590

813

962

747

656

0

0

0

Proceeds from exercise of redeemable convertible preferred stock warrants

-

-

-

-

-

-

-

-

0

Net cash provided by (used in) financing activities

114,775

113,757

111,747

126,458

14,396

15,424

0

0

0

Net change in cash, cash equivalents and restricted cash

12,043

14,191

81,569

95,226

-13,201

-8,541

0

0

0

Supplemental disclosure of cash flow information
Cash paid for interest

4,472

4,234

3,990

3,548

3,028

2,738

0

0

0

Non-cash investing and financing activities:
Accounts payable and accrued liabilities for purchases of property and equipment

32

32

-11

-683

-62

6

0

0

0

Offering costs in accounts payable and accrued liabilities

0

-

-

0

0

-

-

0

0

Right-of-use asset obtained in exchange for lease obligation

0

3,982

0

0

0

-

-

-

-

Redeemable Convertible Preferred Stock
Proceeds from exercise of redeemable convertible preferred stock warrants

1,754

1,784

0

0

0

-

-

-

-